Histogen Stock Working Capital
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
Histogen fundamentals help investors to digest information that contributes to Histogen's financial success or failures. It also enables traders to predict the movement of Histogen Stock. The fundamental analysis module provides a way to measure Histogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Histogen stock.
Histogen |
Histogen Company Working Capital Analysis
Histogen's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Histogen Working Capital | 12.22 M |
Most of Histogen's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Histogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Histogen has a Working Capital of 12.22 M. This is 97.13% lower than that of the Biotechnology sector and 97.73% lower than that of the Health Care industry. The working capital for all United States stocks is 99.17% higher than that of the company.
Histogen Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Histogen's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics of similar companies.Histogen is currently under evaluation in working capital category among its peers.
Histogen Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.54 | |||
| Operating Margin | (705.00) % | |||
| Current Valuation | (4.46 M) | |||
| Shares Outstanding | 4.27 M | |||
| Shares Owned By Insiders | 2.85 % | |||
| Number Of Shares Shorted | 67.03 K | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 4.50 X | |||
| Revenue | 19 K | |||
| Gross Profit | (3.26 M) | |||
| EBITDA | (11.92 M) | |||
| Net Income | (12.38 M) | |||
| Cash And Equivalents | 12.6 M | |||
| Cash Per Share | 5.04 X | |||
| Total Debt | 4.63 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 13.22 X | |||
| Book Value Per Share | 1.27 X | |||
| Cash Flow From Operations | (10.07 M) | |||
| Short Ratio | 4.25 X | |||
| Earnings Per Share | (2.81) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 2.0 | |||
| Beta | 1.12 | |||
| Market Capitalization | 85.44 K | |||
| Total Asset | 19.07 M | |||
| Retained Earnings | (88.27 M) | |||
| Working Capital | 12.22 M | |||
| Net Asset | 19.07 M |
About Histogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Histogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Histogen Stock
Moving against Histogen Stock
| 0.89 | GE | GE Aerospace | PairCorr |
| 0.82 | NVRO | Nevro Corp | PairCorr |
| 0.73 | CSCO | Cisco Systems | PairCorr |
| 0.72 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.66 | JNJ | Johnson Johnson | PairCorr |
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |